Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY16.30 CNY
Change Today +0.46 / 2.90%
Volume 22.2M
000756 On Other Exchanges
Symbol
Exchange
Shenzhen
Hong Kong
Frankfurt
As of 3:00 AM 05/25/15 All times are local (Market data is delayed by at least 15 minutes).

shandong xinhua pharm co-a (000756) Snapshot

Open
CNY15.84
Previous Close
CNY15.84
Day High
CNY16.53
Day Low
CNY15.70
52 Week High
04/15/15 - CNY17.50
52 Week Low
06/19/14 - CNY5.21
Market Cap
6.0B
Average Volume 10 Days
18.7M
EPS TTM
CNY0.11
Shares Outstanding
307.3M
EX-Date
07/18/14
P/E TM
149.5x
Dividend
--
Dividend Yield
0.12%
Current Stock Chart for SHANDONG XINHUA PHARM CO-A (000756)

Related News

No related news articles were found.

shandong xinhua pharm co-a (000756) Related Businessweek News

No Related Businessweek News Found

shandong xinhua pharm co-a (000756) Details

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. Its principal types of goods are bulk pharmaceuticals, preparations, chemical and other products, and commerce circulations. The company offers antipyretics analgesics drugs. It offers the drugs for central nervous system, steroids, and cardio cerebrovascular system, as well as finished dosage forms and pharmaceutical intermediates. It also provides contract manufacturing services of APIs and pharmaceutical intermediates, as well as OTC and generic products. In addition, the company engages in trade and retail of medicine and medical products; the design of medical production projects; the production and sale of calcium polycarbophil materials; the import and export of chemical products and pharmaceuticals; the provision of building management services; the development and management of properties; and provision of mechanical and electrical engineering services. The company operates in the People's Republic of China, Europe, the United States, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo City, the People's Republic of China.

Founded in 1943

shandong xinhua pharm co-a (000756) Top Compensated Officers

General Manager, Executive Director and Membe...
Total Annual Compensation: CNY490.0K
Executive Chairman, Member of Nomination Comm...
Total Annual Compensation: CNY510.0K
Compensation as of Fiscal Year 2013.

shandong xinhua pharm co-a (000756) Key Developments

Shandong Xinhua Pharmaceutical Co. Ltd. Proposes Amendments to Articles of Association

Shandong Xinhua Pharmaceutical Co. Ltd. announced that at the annual general meeting to be held on June 24, 2015 it will propose amendments to the articles of association of the company.

Shandong Xinhua Pharmaceutical Co. Ltd. Proposes Amendments to the Articles of Association

The board of directors of Shandong Xinhua Pharmaceutical Company Limited announced that the Board proposed amendments to be made to Article 142 and Article 143 of the Articles of Association of the company. The proposed Amendments will be submitted to the shareholders of the company for approval by way of special resolution at a general meeting. The company will dispatch a circular containing information relating to, among others, further details of the Proposed Amendments and the general meeting to be held by the company in due course.

Shandong Xinhua Pharmaceutical Co. Ltd. Reports Unaudited Consolidated and Parent Earnings Results for the First Quarter Ended March 31, 2015

Shandong Xinhua Pharmaceutical Co. Ltd. reported unaudited consolidated and parent earnings results for the first quarter ended March 31, 2015. For the quarter, on consolidated basis, the company reported total operating income of RMB 999,523,000 against RMB 936,219,000 a year ago. Operating profit was RMB 19,412,000 against RMB 12,584,000 a year ago. Profit before taxation was RMB 20,902,000 against RMB 10,434,000 a year ago. Profit for the year attributable to owners of the company was RMB 14,259,000 or RMB 0.03 basic and diluted per share against RMB 3,227,000 or RMB 0.01 basic and diluted per share a year ago. Net profit attributable to the shareholders of the Company after extraordinary items was RMB 12,919,000 and net cash flow used in operating activities was RMB 18,148,000. For the quarter, on parent basis, the company reported total operating income of RMB 515,958,000 against RMB 484,657,000 a year ago. Operating profit was RMB 8,799,000 against RMB 8,913,000 a year ago. Profit before taxation was RMB 10,537,000 against RMB 8,664,000 a year ago. Profit after taxation was RMB 8,957,000 or RMB 0.02 basic and diluted per share against RMB 7,499,000 or RMB 0.02 basic and diluted per share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000756:CH CNY16.30 CNY +0.46

000756 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hebei Iron & Steel Co Ltd CNY5.39 CNY +0.13
Nanjing Iron & Steel Co Ltd CNY6.21 CNY +0.25
Wuhan Iron & Steel Co Ltd CNY6.44 CNY +0.14
View Industry Companies
 

Industry Analysis

000756

Industry Average

Valuation 000756 Industry Range
Price/Earnings 100.0x
Price/Sales 2.1x
Price/Book 4.1x
Price/Cash Flow 78.8x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANDONG XINHUA PHARM CO-A, please visit www.xhzy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.